Hypersomnia as a Result of Neurologic Disorders: A Case-based Review
Chinmaye Sapre, Devangi Desai, Soaham Desai
Citation Information :
Sapre C, Desai D, Desai S. Hypersomnia as a Result of Neurologic Disorders: A Case-based Review. Indian Sleep Med 2016; 11 (2):51-58.
Ahmed I, Harris S, Thorpy M. Differential Diagnosis of Hypersomnias. Sleep Medicine Clinics. 2012;7(2):191-204.
A. Brzezinski, “Melatonin in humans,” New England Journal of Medicine, vol. 336, no. 3, pp. 186–195, 1997.
Hypersomnia Associated with Bilateral Posterior Hypothalamic Lesion A Polysomnographic Case Study I. Eisensehra S. Noachtara C. von Schlippenbacha I. Uttnerc J. Kleinea K. Seelosb C. Helmchend
Sallanon M, Denoyer M, Kitahama K, Aubert C, Gay N, Jouvet M: Long-lasting insomnia induced by preoptic neuron lesions and its transient reversal by muscimol injection into the posterior hypothalamus in the cat. Neuro- science 1989;32:669–683.
Guilleminault C., Yuen KM., Gulevich MG., Karadeniz D., Léger D., Philip P. Hypersomnia after head-neck trauma: a methodological dilemma. Neurology. 2000;54:653–659
Schenck CH, Boyd JL, Mahowald MW. A parasomnia overlap disorder involving sleepwalking, sleep terrors, and REM sleep behavior disorder in 33 polysomnographically confirmed cases. Sleep.1997;20(11):972–81. Epub 1998/02/11
Leppävuori A, Pohjasvaara T, Vataja R, Kaste M, Erkinjunntti T. Insomnia in ischemic stroke patients. Cerebrovasc Dis 2002;14:90–97.
Bassetti C, Chervin R. Cerebrovascular diseases. In: Kryger MH, Roth T, Dement WC, editors. Principles and Practice of Sleep Medicine. 3rd edition. Philadelphia: W. B. Saunders; 2000. P. 1072–92
Bassetti C, Mathis J, Gugger M, Lövblad KO, Hess CW. Hypersomnia following thalamic stroke. Ann Neurol 1996;39:471–80
Autret A, Lucas B, Mondon K, Hommet C, Corcia P, Saudeau D, et al. Sleep and brain lesions: a critical review of the literature and additional new cases. Neurophysiol Clin 2001;31:356–75.
Bhat V, Weiner WJ. Parkinson's disease. Diagnosis and the initiation of therapy. Minerva Medica. 96: 145-54.
Adler C, Thorpy M. Sleep issues in Parkinson's disease. Neurology. 2005;64(Issue 12, Supplement 3):S12-S20.
Comella C. Sleep Disorders in Parkinson's Disease. Sleep Medicine Clinics. 2008;3(3):325-335.
Pappert E, Goetz C, Niederman F, Raman R, Leurgans S. Hallucinations, sleep fragmentation, and altered dream phenomena in Parkinson's disease. Mov Disord. 1999;14(1):117-121.
Wienecke M, Werth E, Poryazova R, et al. Progressive dopamine and hypocretin deficiencies in Parkinson's disease: is there an impact on sleep and wakefulness? J Sleep Res. 2012;21:710–717
Mignot E. Sleep, sleep disorders and hypocretin (orexin). Sleep Medicine. 2004;5:S2-S8.
Arii J, Kanbayashi T, Tanabe Y, Sawaishi Y, Kimura S, Watanabe A et al. CSF hypocretin-1 (orexin-A) levels in childhood narcolepsy and neurologic disorders. Neurology. 2004;63(12):2440-2442.
Dalmau J. Clinical analysis of anti-Ma2-associated encephalitis. Brain. 2004;127(8):1831-1844.
Apathy and hypersomnia are common features of myotonic dystrophy J S Rubinsztein, D C Rubinsztein, S Goodburn, A J Holland
D. Hilton-Jones, “Myotonic dystrophy-forgotten aspects of an often neglected condition,” Current Opinion in Neurology, vol. 10, no. 5, pp. 399-401, 1997
J. C. Phemister and J. M. Small, “Hypersomnia in dystrophia myotonica,” Journal of Neurology, Neurosurgery, and Psychiatry, vol. 24, pp. 173–175, 1961.
S. Ono, K. Takahashi, K. Jinnai et al., “Loss of serotonincontaining neurons in the raphe of patients with myotonic dystrophy: a quantitative immunohistochemical study and relation to hypersomnia,”Neurology, vol. 50, no. 2, pp. 535– 538, 1998.
E. Martinez-Rodríguez, L. Lin, A. Iranzo et al., “Decreased hypocretin-1 (orexin-A) levels in the cerebrospinal fluid of patients with myotonic dystrophy and excessive daytime sleepiness,” Sleep, vol. 26, no. 3, pp. 287–290, 2003.
Black JE, Hirshkowitz M. Modafinil for thetreatment of residual excessive sleepiness in nasal continuous positive airway pressure-treated obstructive sleep apnea/hypopnea syndrome. Sleep 2005;28:464-71.
Billiard M, Guilleminault C, Dement WC. (A menstruationlinked periodic hypersomnia. Kleine- Levin syndrome or new clinical entity? Neurology 1975;25:436–43.
American Academy of Sleep Medicine. International Classification of Sleep Disorders.3rd ed. Darien, IL: American Academy of Sleep Medicine; 2014.
Mignot E. Genetic and familial aspects of narco- lepsy. Neurology 1998;50(2 Suppl 1):S16–22.
Thannickal TC, Moore RY, Niehus R, et al. Reduced number of hypocretin neurons in human narcolepsy. Neuron 2000;27:469-74.
Malhotra S, Kushida C. Primary Hypersomnias of Central Origin. CONTINUUM Lifelong Learning in Neurology. 2013;19:67-85.
Bruck D, Parkes JD. A comparison of idiopathic hypersomnia and narcolepsy- cataplexy using self-report measures and sleep diary data. J Neurol Neurosurg Psychiatry 1996;60(5):576Y578.
Montplaisir J, Fantini L. Idiopathic hypersomnia: a diagnostic dilemma. A commentary of “Idiopathic hypersomnia” (M. Billiard and Y. Dauvilliers). Sleep Med Rev 2001;5(5):361Y362.
Critchley M, Hoffman H. The syndrome of periodic somnolence and morbid hunger (Kleine-Levin syndrome). Br Med J 1942;1(4230):137Y139.
Huang YS, Guilleminault C, Kao PF, Liu FY. SPECT findings in the Kleine-Levin syndrome. Sleep 2005;28(8): 955Y960.
Arnulf I, Lin L, Gadoth N, et al. Kleine-Levin syndrome: a systematic study of 108 patients. Ann Neurol 2008;63(4):482Y493.
